On March 7, 2018, Hunton & Williams LLP hosted a webinar with Lisa Sotto, Aaron Simpson, Scott Kimpel and Brittany Bacon on the SEC’s recent cybersecurity guidance.
Continue Reading Webinar Recording Available on SEC Cybersecurity Guidance
Securities and Exchange Commission
SEC Publishes New Guidance on Public Company Cybersecurity Disclosures
On February 21, 2018, the U.S. Securities and Exchange Commission published long-awaited cybersecurity interpretive guidance. The guidance marks the first time that the five SEC commissioners, as opposed to agency staff, have provided guidance to U.S. public companies with regard to their cybersecurity disclosure and compliance obligations. …
Continue Reading SEC Publishes New Guidance on Public Company Cybersecurity Disclosures
SEC Creates Cyber Unit to Target Cyber-Related Threats
This week, the Securities and Exchange Commission announced that it will create a Cyber Unit that will target cyber-related threats that may impact investors. …
Continue Reading SEC Creates Cyber Unit to Target Cyber-Related Threats
SEC Risk Alert Highlights Cybersecurity Improvements and Suggested Best Practices
On August 7, 2017, the Securities and Exchange Commission Office of Compliance Inspections and Examinations issued a Risk Alert examining the cybersecurity policies and procedures of 75 broker-dealers, investment advisers and investment companies. …
Continue Reading SEC Risk Alert Highlights Cybersecurity Improvements and Suggested Best Practices
SEC Warns Initial Coin Offerings May Be Subject to U.S. Federal Securities Laws
Amidst much anticipation, on July 25, 2017, the Securities and Exchange Commission released a Report of Investigation under Section 21(a) of the Securities Exchange Act of 1934 warning the market that “tokens” issued in ICOs may be “securities” such that the full breadth of the U.S. federal securities laws may apply to their offer and sale.
Continue Reading SEC Warns Initial Coin Offerings May Be Subject to U.S. Federal Securities Laws
Chinese Hackers Fined for Hack of New York Law Firms
On May 5, 2017, the U.S. District Court for the Southern District of New York entered a default judgment in favor of the SEC against three Chinese defendants accused of hacking into the nonpublic networks of two New York-headquartered law firms and stealing confidential information regarding several publicly traded companies engaged in mergers and acquisitions.
Continue Reading Chinese Hackers Fined for Hack of New York Law Firms
Email Privacy Act Reintroduced in Congress
On January 9, 2017, Representatives Kevin Yoder (R-KS) and Jared Polis (D-CO) reintroduced the Email Privacy Act, which would amend the Electronic Communications Privacy Act to require government entities to obtain a warrant, based on probable cause, before accessing the content of any emails or electronic communications stored with third-party service providers, regardless of how long the communications have been held in electronic storage by such providers.
Continue Reading Email Privacy Act Reintroduced in Congress
FINRA Issues $14.4 Million in Fines for Inadequate Record Storage Practices
The Financial Industry Regulatory Authority recently announced that it had fined 12 financial institutions a total of 14.4 million dollars for improper storage of electronic broker-dealer and customer records. …
Continue Reading FINRA Issues $14.4 Million in Fines for Inadequate Record Storage Practices
SEC Charges Chinese Traders with Trading on Information Stolen from Law Firms
On December 27, 2016, the Securities and Exchange Commission announced charges against three Chinese traders who allegedly made almost $3 million in illegal profits by fraudulently trading on nonpublic information that had been hacked from two New York-based law firms.
Continue Reading SEC Charges Chinese Traders with Trading on Information Stolen from Law Firms
Pharmaceutical Company to Plead Guilty and Settle Drug Marketing Charges
Recently, Aegerion Pharmaceuticals announced that it will enter into several settlements and plead guilty to two misdemeanors in connection with alleged violations of HIPAA, drug marketing regulations and securities laws. The criminal charges stem from the company’s marketing of a cholesterol drug called Juxtapid. Aegerion allegedly failed to comply with risk evaluation and management strategies and marketed Juxtapid (which is labeled with a warning about liver toxicity) without proper directions for use. …
Continue Reading Pharmaceutical Company to Plead Guilty and Settle Drug Marketing Charges